AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENTThe Collaboration and License Agreement • November 10th, 2005 • Cytokinetics Inc • Pharmaceutical preparations • New York
Contract Type FiledNovember 10th, 2005 Company Industry JurisdictionThis AMENDMENT TO THE COLLABORATION AND LICENSE AGREEMENT (this “Amendment”) is made effective as of September 21, 2005 (the “Amendment Effective Date”) by and between Cytokinetics, Inc., a Delaware corporation (“CK”) and Glaxo Group Limited, a GlaxoSmithKline company, a United Kingdom corporation (“GSK”) (each of CK and GSK a “Party,” together the “Parties”).